Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of ras-responsive gene enhancers in pancreatic tumor cells that express either wild-type or mutant K-ras.

Biochemical and biophysical research communications - 17 Apr 2009

Wilder Phillip J, Chakravarthy Harini, Hollingsworth Michael A, Rizzino Angie

Abstract excerpt

There is a pressing need for new therapies to treat pancreatic cancer. In principle, this could be achieved by taking advantage of signaling pathways that are active in tumor, but not normal, cells. The work described in this study set out to determine whether the activities of three enhancers, which have been reported to be highly responsive to activated ras, differ in pancreatic tumor cells that express...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Culture Media
Share to Enhancer Elements, Genetic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Pancreatic Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Signal Transduction

Source

Identifiers

PMID: 19254697
DOI: 10.1016/j.bbrc.2009.02.126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of ras-responsive gene enhancers in pancreatic tumor cells that express either wild-type or mutant K-ras.PMID 19254697Read ↗

K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivo.Semantic proximity Read ↗

Dominant negative MEKK1 inhibits survival of pancreatic cancer cells.Semantic proximity Read ↗

An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.Semantic proximity Read ↗

Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.Semantic proximity Read ↗

Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.Semantic proximity Read ↗

Expression profiles of pancreatic cancer cell lines infected with antisense K-ras-expressing adenoviral vector.Semantic proximity Read ↗

Survival regulation in pancreatic cancer cells by c-Jun.Semantic proximity Read ↗

Ras activity levels control the development of pancreatic diseases.Semantic proximity Read ↗

Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations.Semantic proximity Read ↗

Genomic instability and histone H3 phosphorylation induction by the Ras-mitogen activated protein kinase pathway in pancreatic cancer cells.Semantic proximity Read ↗

Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.Semantic proximity Read ↗

K-Ras Promotes Growth Transformation and Invasion of Immortalized Human Pancreatic Cells by Raf and Phosphatidylinositol 3-Kinase SignalingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.